Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

AB+ blood group is more common in alopecia areata patients.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Higher cannabis exposure may worsen hair loss.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

A combination of cyclosporine and oral corticosteroid successfully regrew hair in a 19-year-old with alopecia universalis.

Viddhakarma may effectively regrow hair in alopecia areata without side effects.

Placebo effects in alopecia treatments are likely due to study design, not real improvement.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Early-onset hair loss is linked to Parkinson's disease and decreased fertility.

Wigs significantly improve the well-being of people with severe hair loss.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.